|
|
 |
Discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases. |
IPO |
2005 |
|
|
|
 |
Pioneering a new era of in vivo imaging. |
Acquired |
2010 |
 |
|
|
 |
Leading global travel information and advice destination on the web |
Acquired |
2004 |
 |
|
|
 |
Creating novel antibiotics for serious and life-threatening multi-drug resistant infections. |
IPO |
2013 |
|
|
|
Somatogen |
Synthetic hemoglobin products for use in blood transfusion |
Acquired |
1998 |
 |
|
|
 |
Developing resolvins, a novel class of therapies to treat inflammatory diseases and their complications. |
Acquired |
2011 |
.jpg) |
|
|
 |
Discovery, development and commercialization of druts to treat neurological diseases and disorders |
IPO |
2004 |
|
|
|
 |
Developing therapeutic candidates for the treatment of immune and metabolic diseases. |
IPO |
2013 |
|
|
|
 |
Developing novel therapeutics to promote vascular repair. |
Acquired |
2012 |
.jpg) |
|
|
 |
Developer of high-technology purification, analysis and synthesis products |
Acquired |
1998 |
 |
|
|
 |
Developmental biology insights for regenerative medicine therapies |
Acquired |
2000 |
 |
|
|
 |
Genetically diverse organisms for agricultural, life science, and pharmaceutical use |
Acquired |
2007 |
 |
|
|
 |
Software to enable applications transparent use of cluster supercomputers |
Acquired |
2009 |
 |
|
|
 |
Machine intelligence for video security |
Acquired |
2008 |
Tyco International |
|
|
 |
Pharmaceuticals for treatment of metabolic diseases and endocrine disorders |
IPO |
2000 |
|
|
|
 |
Products that enhance the ability of veterinarians to economically provide advanced medical care |
IPO |
1991 |
|
|
|
 |
Platform technology enabling novel therapies for treatment of sleep disorders |
Acquired |
2007 |
 |
|
|
 |
Innovative genetic analysis technologies for the development and marketing of molecular diagnostics tests. |
IPO |
2007 |
|
|
|
 |
Large repository of human DNA, serum and tissue samples linked to detailed clinical information |
Acquired |
2006 |
 |
|
|
 |
Proprietary technologies for the early detection, monitoring and staging of common cancers |
IPO |
2001 |
|
